Literature DB >> 2778069

Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments.

R H See1, S Adilman, K H Bartlett, A W Chow.   

Abstract

Toxic shock syndrome toxin 1 (TSST-1), an exoprotein of Staphylococcus aureus, is strongly implicated in the pathogenesis of TSS. Detection of TSST-1, however, is often hindered in immunoassays because of the cosecretion of protein A, a genetic trait which appears to be coordinately expressed with other exoproteins in S. aureus. We developed a colony immunoblot assay for rapid screening of TSST-1-producing S. aureus using TSST-1-specific rabbit F(ab')2 fragments. The sensitivity and specificity of this method were compared with those of a quantitative noncompetitive enzyme-linked immunosorbent assay (ELISA) for 34 S. aureus isolates (17 TSS-associated and 17 non-TSS-associated isolates). Cosecreted protein A in culture supernatants was evaluated by a quantitative competitive ELISA. The results clearly indicated the superiority of F(ab')2 fragments in eliminating nonspecific reactivity of protein A in the colony immunoblot assay. The sensitivity of the immunoblot with TSST-1-specific F(ab')2 was similar to that with whole immunoglobulin G (94 versus 82%, respectively; P = 0.601, Fisher's exact test), but the specificity was markedly improved (94 versus 59%, respectively; P = 0.039). Among TSST-1-negative isolates (as determined by ELISA), strains which gave false-positive results in the immunoglobulin G immunoblot assay produced higher amounts of protein A than strains which gave true-negative results (P = 0.08, Mann-Whitney rank sum test, one tailed). Among strains positive for TSST-1, the level of TSST-1 detected in culture supernatants correlated inversely with the amount of protein A secreted (rs = -0.64; P less than 0.01, Spearman rank correlation). These findings validate the utility of a rapid screening method for the detection of TSST-1-producing S. aureus and support the concept of coordinate secretion of exoproteins in S. aureus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778069      PMCID: PMC267736          DOI: 10.1128/jcm.27.9.2050-2053.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Significance of protein a production by staphylococci.

Authors:  A Forsgren
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

2.  Regulation of exoprotein gene expression in Staphylococcus aureus by agar.

Authors:  P Recsei; B Kreiswirth; M O'Reilly; P Schlievert; A Gruss; R P Novick
Journal:  Mol Gen Genet       Date:  1986-01

3.  Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.

Authors:  H Igarashi; H Fujikawa; M Shingaki; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1.

Authors:  J Parsonnet; J T Mills; Z A Gillis; G B Pier
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

6.  Comparative evaluation of different enzyme-linked immunosorbent assay systems for the detection of staphylococcal enterotoxins A, B, C, and D.

Authors:  H Fey; H Pfister; O Rüegg
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

7.  Association of toxic shock toxin-1 determinant with a heterologous insertion at multiple loci in the Staphylococcus aureus chromosome.

Authors:  M C Chu; B N Kreiswirth; P A Pattee; R P Novick; M E Melish; J F James
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

9.  Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.

Authors:  P M Rosten; K H Bartlett; A W Chow
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

10.  Interaction of staphylococcal protein A in enzyme-linked immunosorbent assays for detecting staphylococcal antigens.

Authors:  S Notermans; P Timmermans; J Nagel
Journal:  J Immunol Methods       Date:  1982-11-26       Impact factor: 2.303

View more
  6 in total

1.  Immunoblots for detection of toxic shock syndrome toxin 1 produced by Staphylococcus aureus.

Authors:  L S Weckbach; J L Staneck; M R Thompson; P F Bonventre
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Development and evaluation of detection systems for staphylococcal exfoliative toxin A responsible for scalded-skin syndrome.

Authors:  S Ladhani; S Robbie; R C Garratt; D S Chapple; C L Joannou; R W Evans
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 3.  Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

Authors:  S Ladhani; C L Joannou; D P Lochrie; R W Evans; S M Poston
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Oligonucleotide probes for detection and differentiation of Staphylococcus aureus strains containing genes for enterotoxins A, B, and C and toxic shock syndrome toxin 1.

Authors:  R J Neill; G R Fanning; F Delahoz; R Wolff; P Gemski
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

5.  Rapid assay for detection of toxic shock syndrome toxin 1 from human sera.

Authors:  K Miwa; M Fukuyama; T Kunitomo; H Igarashi
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

6.  A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome.

Authors:  J M Musser; P M Schlievert; A W Chow; P Ewan; B N Kreiswirth; V T Rosdahl; A S Naidu; W Witte; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.